Keyphrases
Blood Glutamate Scavengers
65%
Extracellular Glutamate
54%
Glutamate
45%
Neuroprotective Treatment
43%
Antidepressants
41%
Glutamic Pyruvic Transaminase
30%
Phencyclidine
30%
Mesenchymal Stem Cell-derived Extracellular Vesicles
30%
Schizophrenia Models
30%
Patients with Depression
30%
Oxaloacetate
29%
Spinal Cord Injury
26%
Protein Level
24%
Recombinant
24%
COVID-19
21%
Leukocytes
20%
Rat Model
20%
Cerebral Ischemia
20%
Translational Psychiatry
20%
Extremely Low-frequency Electromagnetic Fields (ELF-EMFs)
20%
Major Depressive Disorder
20%
GOT1
18%
Oxaloacetic Acid
18%
Mononuclear Leukocytes
17%
Science Knowledge
15%
Inflammation
15%
Neuroprotective Effect
14%
MRNA Level
14%
Spinal Cord Compression
13%
Intoxication
13%
Paraoxon
13%
Neurological Outcome
12%
Combined Treatment
12%
Seizure
12%
Spinal Cord
11%
Melanoma
11%
Cerebrospinal Fluid
11%
Response Predictors
11%
Rat Cortex
11%
G Protein
11%
Rat Hippocampus
11%
COVID-19 Knowledge
11%
Neurotoxicity
10%
Dental Implants
10%
β-arrestin
10%
Trained Athletes
10%
2-vessel Occlusion
10%
Rat Brain
10%
XML
10%
Arrestin-1
10%
Neuroscience
Glutamic Acid
100%
Neuroprotective Agent
53%
Spinal Cord Injury
41%
Antidepressant
41%
Phencyclidine
30%
Mesenchymal Stem Cell
30%
Dementia Praecox
30%
Major Depressive Disorder
25%
Aspartate Aminotransferase Isoenzyme 1
22%
Brain Ischemia
21%
G Protein
21%
Leukocyte
20%
Psychiatry
20%
Peripheral Blood Mononuclear Cell
18%
Eicosanoid Receptor
12%
In Vivo
11%
Excitotoxicity
11%
Aspartate Aminotransferase
11%
Hippocampus
10%
Neurogenesis
10%
Anti-Inflammatory
10%
G Protein Coupled Receptor Kinase 2
10%
Cell Therapy
10%
Stem Cell
10%
Cellular Differentiation
10%
Crossover Study
10%
Subarachnoid Hemorrhage
10%
Interleukin 10
10%
Long-Term Potentiation
10%
Closed Head Injury
10%
Retina S Antigen
10%
Nerve Agent
10%
Phosducin
10%
Amyotrophic Lateral Sclerosis
10%
Electroporation
10%
In Vitro
10%
Pervasive Developmental Disorder
10%
Cannabis
10%
Mood Disorder
6%
Receptor down Regulation
6%
Behavior (Neuroscience)
6%
Protein Function
5%
Middle Cerebral Artery
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glutamic Acid
92%
Neuroprotective Agent
53%
Oxaloacetic Acid
42%
Antidepressant
30%
Major Depression
23%
Mouse
22%
Aspartate Aminotransferase
20%
Rat Model
20%
Spinal Cord Injury
20%
Brain Ischemia
19%
Guanine Nucleotide Binding Protein
18%
Receptor
15%
Paraoxon
13%
Toxic Injury
13%
Mouse Model
11%
Autism
10%
G Protein Coupled Receptor Kinase 2
10%
Phosducin
10%
Atherosclerosis
10%
Head Injury
10%
Liver Enzyme
10%
Medical Cannabis
10%
Phencyclidine
10%
Extremely Low Frequency
10%
Amyotrophic Lateral Sclerosis
10%
Aspartate Aminotransferase Isoenzyme 1
10%
Gamma Glutamyltransferase
10%
Metastatic Melanoma
10%
Pyruvic Acid
10%
Nerve Gas
10%
Anti-Inflammatory Drug
10%
Electromagnetic Field
10%
Pathophysiology
8%
Normal Human
8%
Desensitization
8%
Brain Hemorrhage
8%
Excitotoxicity
8%
Injury
7%
Recombinant
6%
Alanine
6%
Neoplasm
6%
Mood Disorder
5%
Therapeutic Effect
5%
Middle Cerebral Artery Occlusion
5%
Nervous System Injury
5%
